Despite significant challenges caused by COVID-19 disruptions, the pharmaceutical track-and-trace sector has made strides in three areas to help secure the global supply chain now and well into the future. Read the full article…
In late June 2017, the U.S. Food and Drug Administration announced a one-year delay in the enforcement of the Drug and Supply Chain Security Act’s (DSCSA) requirement for manufacturers to affix or imprint product identifiers to each package or homogeneous case of product. Despite this delay, the pharmaceutical community strives to meet the original deadline. Read the full article…
